Biogen's U.S. commercial chief jumps ship for Sandoz; Amgen takes over most of Glaxo's Prolia marketing;

> Novartis ($NVS) has appointed Richard Frances, a former Biogen Idec ($BIIB) SVP of U.S. commercial operations, to head its Sandoz generics unit. Release

> Pfizer ($PFE) has promoted Monica Piñuela to lead its communications efforts in Spain. News

> Johnson & Johnson ($JNJ) has selected Cohn & Wolfe to support consumer and healthcare communications within the company's Nordic region. More

> Amgen ($AMGN) will take over the marketing of osteoporosis med Prolia from GlaxoSmithKline ($GSK) in areas including the EU, Switzerland, Norway, Russia and Mexico by Dec. 31. Story

> Virgo Consumer Health & Wellbeing has hired Matthew Coy as senior account director and Reena Patel as senior account manager. More

> InVentiv Health has named Michael Griffith as its EVP. Release

> ScripsAmerica ($SCRC) partner Global Pharma Hub has struck an agreement with Jestaw Pharmaceuticals for the Canadian marketing and distribution of RapiMed children's pain reliever and fever reducer. More

> Nutra Pharma ($NPHC) is launching a social media and telemarketing campaign for the distribution of OTC painkiller Nyloxin. Release

> Mannkind Pharma ($MNKD) has selected ADK Fortune as its creative agency. More

And Finally... Canada's provincial health ministers have agreed to ask for a face-to-face meeting with Vertex ($VRTX) to discuss a "fair price" for its cystic fibrosis med Kalydeco. More

Suggested Articles

BMS’ Opdivo-Yervoy combo been game-changing in late-stage melanoma. But when it comes to expanding the pair’s reach, the company has hit a roadblock.

Keytruda's U.S. NSCLC sales might start to fall as soon as early 2020, one analyst says, as I-O rivals eat into its share based on recent successes.

A small group of physicians expressed little interest in new MS drugs from Novartis, Merck KGaA and Biogen but favored a repurposed therapy.